Accurate segregation of retinal blood vessels network plays a crucial role in clinical assessments, treatments, and rehabilitation process. Owing to the presence of acquisition and instrumentation anomalies, precise tracking of vessels network is challenging. For this, a new fundus image segmentation framework is proposed by combining deep neural networks, and hidden Markov model. It has three main modules: the Atrous spatial pyramid pooling-based encoder, the decoder, and hidden Markov model vessel tracker. The encoder utilized modified ResNet18 deep neural networks model for low-and-high-levels features extraction. These features are concatenated in module-II by the decoder to perform convolution operations to obtain the initial segmentation. Previous modules detected the main vessel structure and overlooked some small capillaries. For improved segmentation, hidden Markov model vessel tracker is integrated with module-I and-II to detect overlooked small capillaries of the vessels network. In last module, final segmentation is obtained by combining multi-oriented sub-images using logical OR operation. This novel framework is validated experimentally using two standard DRIVE and STARE datasets. The developed model offers high average values of accuracy, area under the curve, and sensitivity of 99.8, 99.0, and 98.2%, respectively. Analysis of the results revealed that the developed approach offered enhanced performance in terms of sensitivity 18%, accuracy 3%, and specificity 1% over the state-of-the-art approaches. Owing to better learning and generalization capability, the developed approach tracked blood vessels network efficiently and automatically compared to other approaches. The proposed approach can be helpful for human eye assessment, disease diagnosis, and rehabilitation process.

Long non-coding RNAs (lncRNAs) are important regulators of biological processes. It has recently been shown that some lncRNAs include small open reading frames (sORFs) that can encode small peptides of no more than 100 amino acids. However, existing methods are commonly applied to human and animal datasets and still suffer from low feature representation capability. Thus, accurate and credible prediction of sORFs with coding ability in plant lncRNAs is imperative. This paper proposes a new method termed sORFPred, in which we design a model named MCSEN by combining multi-scale convolution and Squeeze-and-Excitation Networks to fully mine distinct information embedded in sORFs, integrate and optimize multiple sequence-based and physicochemical feature descriptors, and built a two-layer prediction classifier based on Bayesian optimization algorithm and Extra Trees. sORFPred has been evaluated on sORFs datasets of three species and experimentally validated sORFs dataset. Results indicate that sORFPred outperforms existing methods and achieves 97.28% accuracy, 97.06% precision, 97.52% recall, and 97.29% F1-score on Arabidopsis thaliana, which shows a significant improvement in prediction performance compared to various conventional shallow machine learning and deep learning models.

Differentiation of ductal carcinoma in situ (DCIS, a precancerous lesion of the breast) from fibroadenoma (FA) using ultrasonography is significant for the early prevention of malignant breast tumors. Radiomics-based artificial intelligence (AI) can provide additional diagnostic information but usually requires extensive labeling efforts by clinicians with specialized knowledge. This study aims to investigate the feasibility of differentially diagnosing DCIS and FA using ultrasound radiomics-based AI techniques and further explore a novel approach that can reduce labeling efforts without sacrificing diagnostic performance. We included 461 DCIS and 651 FA patients, of whom 139 DCIS and 181 FA patients constituted a prospective test cohort. First, various feature engineering-based machine learning (FEML) and deep learning (DL) approaches were developed. Then, we designed a difference-based self-supervised (DSS) learning approach that only required FA samples to participate in training. The DSS approach consists of three steps: (1) pretraining a Bootstrap Your Own Latent (BYOL) model using FA images, (2) reconstructing images using the encoder and decoder of the pretrained model, and (3) distinguishing DCIS from FA based on the differences between the original and reconstructed images. The experimental results showed that the trained FEML and DL models achieved the highest AUC of 0.7935 (95% confidence interval, 0.7900-0.7969) on the prospective test cohort, indicating that the developed models are effective for assisting in differentiating DCIS from FA based on ultrasound images. Furthermore, the DSS model achieved an AUC of 0.8172 (95% confidence interval, 0.8124-0.8219), indicating that our model outperforms the conventional radiomics-based AI models and is more competitive.

Drug-drug interaction refers to taking the two drugs may produce certain reaction which may be a threat to patients' health, or enhance the efficacy helpful for medical work. Therefore, it is necessary to study and predict it. In fact, traditional experimental methods can be used for drug-drug interaction prediction, but they are time-consuming and costly, so we prefer to use more accurate and convenient calculation methods to predict the unknown drug-drug interaction. In this paper, we proposed a deep learning framework called MSResG that considers multi-sources features of drugs and combines them with Graph Auto-Encoder to predicting. Firstly, the model obtains four feature representations of drugs from the database, namely, chemical substructure, target, pathway and enzyme, and then calculates the Jaccard similarity of the drugs. To balance different drug features, we perform similarity integration by finding the mean value. Then we will be comprehensive similarity network combined with drug interaction network, and encodes and decodes it using the graph auto-encoder based on residual graph convolution network. Encoding is to learn the potential feature vectors of drugs, which contain similar information and interaction information. Decoding is to reconstruct the network to predict unknown drug-drug interaction. The experimental results show that our model has advanced performance and is superior to other existing advanced methods. Case study also shows that MSResG has practical significance.

Accurately detecting linear B-cell epitopes (BCEs) makes great sense in vaccine design, immunodiagnostic test, antibody production, disease prevention and treatment. Wet-lab experiments for determining linear BCEs are both expensive and laborious, which are not able to meet the recognition needs of modern massive protein sequence data. Instead, computational methods can efficiently identify linear BCEs with low cost. Although several computational methods are available, the performance is still not satisfactory. Thus, we propose a new method, LBCE-XGB, to forecast linear BCEs based on XGBoost algorithm. To represent the biological information concealed in peptide sequences, the embeddings of the residues were obtained from a pre-trained domain-specific BERT model. In addition, the other five types of attributes comprising amino acid composition, amino acid antigenicity scale were also extracted. The best feature combination was determined according to the cross-validation results. Against the models developed by other deep learning and machine learning algorithms, LBCE-XGB achieves the top performance with an AUROC of 0.845 for fivefold cross-validation. The results on the independent test set show that our model attains an AUROC of 0.838 which is substantially higher than other state-of-the-art methods. The outcomes indicate that the representations of BERT could be an effective feature in predicting linear BCEs and we believe that LBCE-XGB could be a useful medium for detecting linear B cell epitopes with high accuracy and low cost.

This review article summarizes the recent advances in the diagnostic studies of autism spectrum disorders (ASDs) considering some of the most influential research articles from the last two decades. ASD is a heterogeneous neurodevelopmental disorder characterized by abnormalities in social interaction, communication, and behavioral patterns as well as some unique strengths and differences. The current diagnosis systems are based on autism diagnostic observation schedule (ADOS) or autism diagnostic interview-revised (ADI-R), but biological markers are also important for an effective diagnosis of ASDs. The amalgamation of neuroimaging techniques, such as structural and functional magnetic resonance imaging (sMRI and fMRI), with machine-learning and deep-learning approaches helps throw new light on typical biological markers of ASDs at the early stage of life. To assess the performance of a deep neural network, we develop a light-weighted CNN model for ASD classification. The overall accuracy, precision, and F1-score of the proposed model are 99.92%, 99.93% and 99.92%, respectively. All the neuroimaging studies we have reviewed can be divided into 3 categories, viz. thickness, volume and functional connectivity-based studies. We conclude with a discussion of the major findings of considered studies and promising directions for future research in this field.